Adults meeting the studys obesity criteria, who newly initiated tirzepatide or semaglutide, were identified and compared with matched individuals who started naltrexone-bupropion, phentermine, or phentermine-topiramate
According to the New England Journal of Medicine phase 2 clinical trial involving 338 adults, retatrutide showed significant weight loss, which was mainly dose-dependent
No lethal dose has been established for BPC-157 in animal models, and it demonstrates consistent protection against drug-induced and surgical organ damage. Perovic, D
When fat volume decreases faster than the skin can contract, laxity becomes more visible, especially in the face, neck, arms, abdomen, and thighs
How to Maintain Results Consume a healthy and light meal
House of Representatives